Hydroxychloroquine versus hydroxychloroquine-azithromycin combination therapy on QT interval prolongation of COVID-19 patients: a systematic review and meta-analysis
نویسندگان
چکیده
VĂ˝zkum zamÄĹenĂ˝ na lĂŠÄbu onemocnÄnĂ COVID-19 vedl k pouĹžitĂ hydroxychlorochinu (HCQ) jako jednĂŠ z moĹžnostĂ lĂŠÄby. ĂÄinnost HCQ lze zvýťit jeho podĂĄvĂĄnĂm v kombinaci s azitromycinem (AZM). Hydroxychlorochin vĹĄak mĹŻĹže spouĹĄtÄt arytmie podobÄ prodlouĹženĂ intervalu QT. PĹidĂĄnĂ AZM by rovnÄĹž mohlo riziko ProtoĹže mechanismus ĂşÄinku tÄchto lĂĄtek stĂĄle nenĂ pĹesnÄ znĂĄm, je naprosto nezbytnĂŠ provĂŠst systematickĂ˝ pĹehled vĂ˝sledkĹŻ dosavadnĂho vĂ˝zkumu. CĂlem pĹedloĹženĂŠ studie bylo porovnat incidenci QT u pacientĹŻ onemocnÄnĂm lĂŠÄenĂ˝ch a kombinacĂ HCQ-AZM. UspoĹĂĄdĂĄnĂm se jednalo o komparativnĂ studii dvou samostatnĂ˝ch skupin pacientĹŻ. Ădaje byly shromaĹžÄovĂĄny ÄasopisĹŻ publikovanĂ˝ch online obdobĂ od ledna do Äervence 2020, nichĹž srovnĂĄvala incidence buÄ samotnĂ˝m, nebo HCQ-AZM; ÄlĂĄnky nĂĄslednÄ zaĹazeny systematickĂŠho pĹehledu. Bylo nalezeno pÄt studiĂ splĹujĂcĂch zadanĂĄ kritĂŠria; vĂ˝slednĂ˝ vzorek zahrnoval 477 osob ve Francii USA. zpracovĂĄny formou deskriptivnĂ statistickĂŠ analĂ˝zy. StatistickĂĄ analĂ˝za provĂĄdÄla pomocĂ fixnĂho modelu pouĹžitĂm poolovanĂ˝ch ĂşdajĹŻ. AnalĂ˝za nenalezla ŞådnĂ˝ statisticky vĂ˝znamnĂ˝ rozdĂl vĂ˝skytu mezi skupinami lĂŠÄenĂ˝mi pouze HCQ, HCQ-AZM (OR 1,294; 95% CI 0,707-2,370). © 2021, ÄKS.
منابع مشابه
Prevalence of Comorbidities in COVID-19 Patients: A Systematic Review and Meta-Analysis
Background: In this study, we aimed to assess the prevalence of comorbidities in the confirmed COVID-19 patients. Thismight help showing which comorbidity might pose the patients at risk of more severe symptoms.Methods: We searched all relevant databases on April 7th, 2020 using the keywords (“novel coronavirus” OR COVID-19OR SARS-CoV-2 OR Coronavirus) AND (comorbidities OR cl...
متن کاملHydroxychloroquine: A bridge prophylaxis till finding the COVID-19 vaccine
Regarding the importance of COVID-19 pandemic and risks that the infection imposes on healthcare workers, this manuscript discusses the potential usage of Hydroxychloroquine as a prophylactic agent.
متن کاملEFFICACY AND SAFETY OF FAVIPIRAVIR IN PATIENTS WITH COVID-19: A REVIEW OF SYSTEMATIC REVIEWS AND META-ANALYSIS
Background & Aims: Favipiravir is an antiviral drug that is widely used in patients with Covid-19. The aim of this study was to review the systematic review and meta-analysis studies of Favipiravir in patients with Covid-19. Materials & Methods: An electronic search was conducted in PubMed, Scopus, Cochrane Library, and Web of Science databases until December 2021. In addition, other database...
متن کاملEstimating the Relationship between Serum Electrolytes and COVID-19: A systematic Review and Meta-Analysis
Background and purpose: There are controversies on the association between electrolytes and Coronavirus disease 2019 (COVID-19) and its severity. Studies on these issues may help in resolving ambiguities. The purpose of this study was to assess the association between electrolyte indices and being infected with COVID-19 and developing severe symptoms using a meta-analysis. Materials and method...
متن کاملIs hydroxychloroquine effective in treating primary Sjogren’s syndrome: a systematic review and meta-analysis
BACKGROUND To systematically review and assess the efficacy and safety of hydroxychloroquine (HCQ) for treating primary Sjogren's syndrome (pSS). METHODS Five electronic databases (Pubmed, EMBASE, Web of science, Ovid, Cochrane Library) were searched for randomized controlled trials and retrospective or prospective studies published in English that reported the effect of HCQ on pSS. The subje...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cor et vasa
سال: 2021
ISSN: ['0010-8650', '1803-7712']
DOI: https://doi.org/10.33678/cor.2021.025